GSA CAPITAL PARTNERS LLP - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 241 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$819
-99.9%
21,852
-36.5%
0.08%
-22.9%
Q1 2021$631,000
+25.2%
34,425
+4.3%
0.10%
+320.0%
Q2 2018$504,000
+26.0%
33,000
+47.3%
0.02%
-7.4%
Q3 2017$400,000
-61.6%
22,400
-60.4%
0.03%
-56.5%
Q4 2016$1,042,000
+203.8%
56,544
+212.4%
0.06%
+244.4%
Q3 2016$343,000
+109.1%
18,100
+57.4%
0.02%
+125.0%
Q4 2015$164,000
+12.3%
11,500
-7.9%
0.01%
+14.3%
Q3 2015$146,000
-32.1%
12,486
-13.3%
0.01%
-22.2%
Q1 2015$215,000
-38.9%
14,400
-52.5%
0.01%
-64.0%
Q4 2014$352,00030,3000.02%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
EAM Investors, LLC 173,018$3,187,0000.42%
GLOBEFLEX CAPITAL L P 50,686$934,0000.23%
KALMAR INVESTMENTS INC /DE/ 240,648$4,433,0000.23%
ESSEX INVESTMENT MANAGEMENT CO LLC 63,661$1,173,0000.19%
OBERWEIS ASSET MANAGEMENT INC/ 27,200$501,0000.15%
Invictus RG 11,950$220,0000.15%
ACADIAN ASSET MANAGEMENT LLC 1,502,151$27,668,0000.13%
FOX RUN MANAGEMENT, L.L.C. 12,600$232,0000.12%
Piermont Capital Management Inc. 26,153$482,0000.11%
FEDERATED HERMES, INC. 1,344,684$24,769,0000.07%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders